Powerful Medical
11. July 2023

Press Release: AI-Powered Diagnostics Platform PMcardio Now Accessible to Healthcare Professionals in 15 New European Markets

PMcardio, a leading force in AI-powered diagnostics for cardiovascular diseases, announces its expansion into 15 additional European markets with the launch of its newest version.

After a successful initial launch in the United Kingdom, with over 25 000 registered users, PMcardio is now making its state-of-the-art application accessible to healthcare professionals in Germany, France, Belgium, The Netherlands, Austria, Switzerland, Portugal, Italy, Luxembourg, Lichtenstein, Cyprus, Poland, Ireland, Croatia and Malta. PMcardio has further fine-tuned its clinical assistant, offering new language support for French, German, Italian and Portuguese, ensuring a seamless experience for healthcare professionals across these diverse regions.

For medical professionals in primary care who do not specialise in cardiology, such as GPs, nurses and paramedics – ECG interpretation can be challenging, leading to inaccuracies and potential misdiagnoses.

“The increasing prevalence of diseases such as atrial fibrillation, a condition that one in three people will experience in their lifetime, highlights a pressing need for more reliable solutions for early detection and effective treatment, states Dr. Robert Herman, Chief Medical Officer of Powerful Medical, the deep-tech firm behind PMcardio. “This condition significantly escalates the risk of stroke, making prompt and accurate diagnosis critical. PMcardio is poised to enhance AF diagnosis and management at the first point of contact.”

Easily accessible in the form of a smartphone application, PMcardio enables any healthcare professional to diagnose and treat 38 cardiovascular diseases with the precision of a cardiologist.

Not only does the CE-certified Class IIb medical device empower medical personnel to interpret ECGs and identify cardiac conditions with precision and speed – it also generates guideline-adherent treatment recommendations personalised for each patient.

“With PMcardio we’re aiming to save 1 million lives within the next 5 years. This European expansion is a significant leap in PMcardio’s mission to combat cardiovascular diseases, the world’s leading cause of death. Its integration can significantly improve clinical decision-making, quality of care and outcomes of patients suffering from heart disease across Europe,” concludes Martin Herman, CEO of Powerful Medical.

Powerful Medical

Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
About PMcardio:

PMcardio is the market leader in AI-powered diagnostics, addressing the world’s leading cause of death – cardiovascular diseases. The innovative clinical assistant empowers healthcare professionals to detect up to 40 cardiovascular diseases. In the form of a smartphone application, the certified Class IIb medical device interprets any 12-lead ECG image in under 5 seconds to provide accurate diagnoses and individualized treatment recommendations tailored to each patient.

About Powerful Medical:

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Don't miss these

Wellens syndrom ECG - Blog

Facing Wellens’ Syndrome: Are You Prepared to Prevent Acute Coronary Occlusions?

Wellens' Syndrome is a condition representing a reperfusion state post coronary artery occlusion, marked by distinctive ECG changes. This condition demands urgent recognition and intervention to prevent the progression to an extensive anterior wall myocardial infarction (MI).

Gearing Up for the US Market: PMcardio Showcases at ACC.24

We're thrilled to share our experience at the American College of Cardiology's 24th annual meeting (ACC.24) in Atlanta, where we showcased our AI-powered ECG interpretation platform

Join 25,000 healthcare professionals who are already taking advantage of AI